8,915 Shares in iShares U.S. Healthcare ETF $IYH Purchased by Caprock Group LLC

Caprock Group LLC bought a new stake in iShares U.S. Healthcare ETF (NYSEARCA:IYH) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 8,915 shares of the company’s stock, valued at approximately $516,000.

Other institutional investors also recently added to or reduced their stakes in the company. Financial Perspectives Inc bought a new stake in shares of iShares U.S. Healthcare ETF in the second quarter valued at approximately $30,000. SJS Investment Consulting Inc. bought a new position in iShares U.S. Healthcare ETF during the third quarter worth $36,000. Assetmark Inc. raised its stake in iShares U.S. Healthcare ETF by 98.4% during the 2nd quarter. Assetmark Inc. now owns 734 shares of the company’s stock valued at $41,000 after purchasing an additional 364 shares during the last quarter. First Horizon Corp bought a new stake in iShares U.S. Healthcare ETF in the 3rd quarter valued at $51,000. Finally, CENTRAL TRUST Co grew its position in iShares U.S. Healthcare ETF by 108.7% in the 2nd quarter. CENTRAL TRUST Co now owns 960 shares of the company’s stock worth $54,000 after purchasing an additional 500 shares during the last quarter.

iShares U.S. Healthcare ETF Stock Performance

NYSEARCA:IYH opened at $65.71 on Wednesday. The firm’s 50-day moving average is $65.49 and its 200-day moving average is $62.04. The company has a market cap of $3.53 billion, a price-to-earnings ratio of 21.05 and a beta of 0.65. iShares U.S. Healthcare ETF has a 52-week low of $53.35 and a 52-week high of $67.63.

iShares U.S. Healthcare ETF Profile

iShares U.S. Healthcare ETF (the Fund), formerly iShares Dow Jones U.S. Healthcare Sector Index Fund (the Fund) is a non-diversified exchange-traded fund. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Dow Jones U.S. Health Care Index (the Index). The Index measures the performance of the healthcare sector of the United States equity market, and includes companies in the industry groups, such as healthcare equipment and services, pharmaceuticals and biotechnology.